Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Re (RMAX) EBITDA (2016 - 2025)

Re (RMAX) has disclosed EBITDA for 14 consecutive years, with $9.9 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 103.61% to $9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.4 million through Dec 2025, up 16.12% year-over-year, with the annual reading at $49.4 million for FY2025, 16.12% up from the prior year.
  • EBITDA for Q4 2025 was $9.9 million at Re, down from $18.9 million in the prior quarter.
  • The five-year high for EBITDA was $18.9 million in Q3 2025, with the low at -$37.6 million in Q3 2021.
  • Average EBITDA over 5 years is $5.5 million, with a median of $8.0 million recorded in 2022.
  • The sharpest move saw EBITDA plummeted 501.11% in 2023, then soared 175.3% in 2024.
  • Over 5 years, EBITDA stood at $10.4 million in 2021, then dropped by 18.88% to $8.5 million in 2022, then plummeted by 214.58% to -$9.7 million in 2023, then soared by 150.22% to $4.9 million in 2024, then soared by 103.61% to $9.9 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $9.9 million, $18.9 million, and $14.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.